No Picture
News

Decipher Biosciences Announces its Genomic Data Featured at 2019 Genitourinary Conference in Multiple Prostate Cancer Presentations

SAN DIEGO, Feb. 14, 2019 /PRNewswire/ — Decipher Biosciences (formerly GenomeDx Inc.), a leader in the field of urologic cancer genomics, today announced that it will present results from seven studies featuring its Decipher® Prostate and Bladder C… […]

No Picture
News

Epic Sciences to Present at ASCO-GU 2019 New Data Demonstrating Utility of Liquid Biopsy to Optimize Drug Development

SAN DIEGO, Feb. 12, 2019 /PRNewswire/ — Epic Sciences, Inc. (Epic) announced today the presentation of four posters at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU), held in San Francisco on February 14-1… […]

No Picture
News

Southern California Philanthropists Richard and Melanie Lundquist Make $70 Million Unrestricted Gift to LA BioMed, Will Be Renamed Lundquist Institute

Funds will go toward recruiting top researchers and improving facilities in the South Bay region of LA County – one of the nation’s top ten biotech clusters

LOS ANGELES, Feb. 11, 2019 /PRNewswire/ — Southern California philanthropists Melanie and Ri… […]

No Picture
News

Published Case Series Indicates the Ability of Biocept’s Liquid Biopsy Testing to Identify Actionable Biomarkers When Tissue Biopsy Is Unsuccessful

Peer-reviewed article in journal, Clinics in Oncology, further supports the clinical utility of Biocept’s Target Selector(TM) platform to aid physicians in the selection of targeted therapy for patients with lung cancer

SAN DIEGO, Feb. 5, 2019 /PRNew… […]

No Picture
News

argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology

— argenx gains access to ENHANZE® subcutaneous delivery technology for up to three targets, including exclusive rights to develop therapeutic products targeting human neonatal Fc receptor FcRn —

BREDA, the Netherlands and GHENT, Belgium and S… […]